| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1331940 | 6480464 | Ethinyl Estradiol results in increased expression of DLGAP4 mRNA | CTD | PMID:17555576 PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1331940 | 6480464 | Ethinyl Estradiol results in increased expression of DLGAP4 mRNA | CTD | PMID:17942748 PMID:17555576 |
| 17beta-estradiol | decreases expression | ISO | RGD:1605091 | 6480464 | Estradiol results in decreased expression of DLGAP4 mRNA | CTD | PMID:19167446 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1331940 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DLGAP4 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1331940 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DLGAP4 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1331940 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DLGAP4 promoter] | CTD | PMID:19654925 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of DLGAP4 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:1605091 | 6480464 | beta-methylcholine affects the expression of DLGAP4 mRNA | CTD | PMID:21179406 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of DLGAP4 mRNA | CTD | PMID:19162173 |
| aflatoxin B1 | increases expression | ISO | RGD:1331940 | 6480464 | Aflatoxin B1 results in increased expression of DLGAP4 mRNA | CTD | PMID:19770486 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of DLGAP4 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1331940 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of DLGAP4 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:1331940 | 6480464 | Benzo(a)pyrene results in increased expression of DLGAP4 mRNA | CTD | PMID:22228805 |
| bisphenol A | decreases expression | ISO | RGD:1605091 | 6480464 | bisphenol A results in decreased expression of DLGAP4 mRNA | CTD | PMID:20678512 |
| choline | multiple interactions | ISO | RGD:1331940 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DLGAP4 gene | CTD | PMID:20938992 |
| cobalt dichloride | increases expression | ISO | RGD:1605091 | 6480464 | cobaltous chloride results in increased expression of DLGAP4 mRNA | CTD | PMID:19376846 |
| cyclosporin A | increases expression | ISO | RGD:1605091 | 6480464 | Cyclosporine results in increased expression of DLGAP4 mRNA | CTD | PMID:20106945 |
| diarsenic trioxide | decreases expression | ISO | RGD:1605091 | 6480464 | arsenic trioxide results in decreased expression of DLGAP4 mRNA | CTD | PMID:22521957 |
| folic acid | multiple interactions | ISO | RGD:1331940 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DLGAP4 gene | CTD | PMID:20938992 |
| hydroquinone O-beta-D-glucopyranoside | increases expression | ISO | RGD:1605091 | 6480464 | Arbutin results in increased expression of DLGAP4 mRNA | CTD | PMID:17103032 |
| kojic acid | increases expression | ISO | RGD:1605091 | 6480464 | kojic acid results in increased expression of DLGAP4 mRNA | CTD | PMID:16595896 |
| L-methionine | multiple interactions | ISO | RGD:1331940 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DLGAP4 gene | CTD | PMID:20938992 |
| lead(0) | increases expression | ISO | RGD:1605091 | 6480464 | Lead results in increased expression of DLGAP4 mRNA | CTD | PMID:19921347 |
| paracetamol | affects expression | ISO | RGD:1331940 | 6480464 | Acetaminophen affects the expression of DLGAP4 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1605091 | 6480464 | Acetaminophen results in increased expression of DLGAP4 mRNA | CTD | PMID:21420995 |
| phenobarbital | multiple interactions | ISO | RGD:1331940 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DLGAP4 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of DLGAP4 mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | ISO | RGD:1331940 | 6480464 | Phenobarbital results in increased expression of DLGAP4 mRNA | CTD | PMID:19482888 |
| tamoxifen | affects expression | ISO | RGD:1331940 | 6480464 | Tamoxifen affects the expression of DLGAP4 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1605091 | 6480464 | tert-Butylhydroperoxide results in increased expression of DLGAP4 mRNA | CTD | PMID:15336504 |
| zoledronic acid | decreases expression | ISO | RGD:1605091 | 6480464 | zoledronic acid results in decreased expression of DLGAP4 mRNA | CTD | PMID:20977926 |